Integral Diagnostics Limited (ASX:IDX)

Market Cap	972.78M
Revenue (ttm)	627.22M
Net Income (ttm)	4.67M
Shares Out	372.71M
EPS (ttm)	0.02
PE Ratio	173.27
Forward PE	20.62
Dividend	0.07 (2.54%)
Ex-Dividend Date	Aug 29, 2025

Volume	262,404
Average Volume	617,291
Open	2.575
Previous Close	2.560
Day's Range	2.560 - 2.620
52-Week Range	1.910 - 3.150
Beta	0.16
RSI	58.72
Earnings Date	Feb 23, 2026

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX